Print

AVEG 023

Trial Details:

I Completed
National Institute of Allergy and Infectious Diseases (NIAID) May 18, 1995
UBI HIV-1 Peptide Vaccine, Microparticulate Monovalent Env V3 loop gp120 B MN
UBI HIV-1 Peptide Immunogen, Multivalent Protein
USA 36
NCT00000846
http://www.clinicaltrials.gov/ct2/show/NCT00000846